OpenAlex
PricingAboutJobs
Log inGet started
Work

Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy

HTML

Year: 2013
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-13-0081
Authors: Yvonne Kienast, Christian Klein, Werner Scheuer, Romi Raemsch, Erica Lorenzon, Dirk Bernicke, Frank Herting, Sidney Yu, Huynh Hung The, Laurent Martarello, Christian Gassner, Kay-Gunnar Stubenrauch, Kate Munro, Hellmut G. Augustin, Markus Thomas
Institutions: F. Hoffmann-La Roche AG, German Cancer Research Center, Heidelberg University, Singapore General Hospital, Roche (United Kingdom), National Cancer Centre Singapore, DKFZ-ZMBH Alliance, Medizinische Fakultät Mannheim
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: bispecific antibodies, angiopoietin-2, bevacizumab, tumor angiogenesis, anti-angiogenic therapy, metastasis suppression, tumor xenografts, combination chemotherapy, tumor hypoxia, vessel maturation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2107252679
FWCI: 5.902
Cites: 50
Cited by: 215
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security